STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trialMatthew J. Reilley, David S. Hong, Samantha J. Lee et al.|Journal for ImmunoTherapy of Cancer|2018Cited by 286